Expression Systems:
Reconstitution: Lyophilized protein is soluble in sterile water (≥100 µg/mL) and stable in PBS (pH 7.4) .
IL-1 alpha Mouse, His binds the IL-1 receptor type 1 (IL-1R1), activating downstream signaling via MyD88 and NF-κB pathways . Key activities include:
Pro-Inflammatory Effects: Synergizes with TNF-α to induce fever, neutrophil recruitment, and acute-phase proteins .
Immune Cell Activation: Stimulates macrophages, fibroblasts, and endothelial cells to secrete cytokines (e.g., IL-6, CXCL1/KC) .
Wound Healing: Promotes keratinocyte proliferation and growth factor release (FGF, EGF) .
Skin Inflammation: IL-1α drives neutrophilic dermatoses in Ptpn6 mutant mice. Genetic ablation of IL-1α (but not IL-1β) prevents disease progression .
Autoinflammatory Disorders: CRISPR-generated Il1a-KO line2 mice exhibit normal IL-1β expression, clarifying IL-1α-specific roles in chronic inflammation .
COVID-19: Anakinra (IL-1α/β inhibitor) reduced clinical progression in trials, whereas IL-1β-specific blockers (e.g., canakinumab) showed no efficacy, underscoring IL-1α’s dominance in hyperinflammation .
KC/CXCL1 Production: IL-1α-deficient macrophages show impaired neutrophil chemoattractant release, validating its role in innate immunity .
Radiation Protection: IL-1α mitigates γ-irradiation lethality in mice via hematopoietic recovery .
Model Limitations: Earlier Il1a-KO line1 mice showed reduced IL-1β expression, confounding phenotype interpretation. The CRISPR-generated line2 model resolves this .
Therapeutic Targeting: IL-1α’s dual nuclear/cytosolic localization complicates drug design, necessitating cell-specific delivery strategies .
Recent advancements in IL-1α mouse models have clarified distinct roles of IL-1α independent of IL-1β, resolving long-standing contradictions in the field. The development of the CRISPR-Cas9 generated IL-1α knockout mouse line (IL-1α-KO line2) has addressed previous limitations in studying IL-1α function. This model demonstrates that IL-1α specifically regulates KC/CXCL1 expression, while confirming that IL-1β production is not dependent on IL-1α as previously thought .
IL-1α is a founding member of the IL-1 cytokine family and functions as a critical inflammatory mediator in both host defense and disease pathogenesis. Unlike IL-1β, which requires processing by inflammasomes for activation, IL-1α can act as both a nuclear transcription regulator and a cytokine when released. The distinct functions of IL-1α include specific regulation of neutrophil chemoattractant KC/CXCL1, which is not dependent on IL-1β . Methodologically, researchers can distinguish IL-1α activity by measuring KC/CXCL1 levels following stimulation with PAMPs or pathogens, as IL-1α knockout significantly reduces KC production while IL-1β knockout does not affect or even increases KC levels .
Two primary approaches have been used to generate IL-1α knockout mice:
Traditional gene targeting (IL-1α-KO line1): This earlier model showed interdependent expression of IL-1α and IL-1β, with substantial reduction in IL-1β production when IL-1α was deleted .
CRISPR-Cas9 technology (IL-1α-KO line2): This newer approach targeted exons 2-5 of the IL-1α gene by simultaneous injection of two guide RNAs with Cas9 mRNA into pronuclear-staged C57BL/6J zygotes . Verification of successful deletion is performed through:
This improved model shows normal IL-1β induction in response to microbial PAMPs and pathogens, enabling more precise study of IL-1α-specific functions .
While the search results don't specifically mention His-tagged IL-1α, His-tagging is a common approach for protein purification and detection in research. For IL-1α research, His-tagged recombinant proteins can be used to study binding interactions with the IL-1 receptor, evaluate antibody specificity, and investigate protein-protein interactions. When designing experiments with His-tagged IL-1α, researchers should verify that the tag doesn't interfere with the protein's biological activity through functional assays comparing tagged and untagged versions .
Distinguishing IL-1α-specific effects requires careful experimental design using appropriate knockout models. The newer CRISPR-generated IL-1α-KO line2 offers significant advantages because:
It shows normal induction and activation of IL-1β in response to stimuli
It demonstrates normal inflammasome activation
Methodologically, researchers should:
Use both IL-1α and IL-1β knockout models in parallel experiments
Measure multiple inflammatory markers (not just IL-1β levels)
Evaluate temporal dynamics of cytokine production (early vs. late timepoints)
Consider using neutralizing antibodies as complementary approaches
A specific protocol involves stimulating bone marrow-derived macrophages with LPS or pathogens and measuring both IL-1β and KC/CXCL1 production by ELISA or western blot, where KC production will be significantly reduced only in IL-1α knockout cells .
The conflicting results observed between different IL-1α knockout lines highlight important considerations for experimental design and interpretation:
Verify the genetic background of the knockout line (extensive backcrossing to C57BL/6 is recommended)
Characterize the molecular defect in each knockout line (deletion size, potential off-target effects)
Assess temporal dynamics of cytokine production (the IL-1α-KO line1 showed pronounced reduction in IL-1β only at early timepoints)
Consider context-dependent effects (acute vs. chronic inflammation)
Validate findings using complementary approaches (neutralizing antibodies, conditional knockouts)
When publishing results, researchers should clearly specify which knockout line was used and discuss potential limitations of the model. For chronic disease studies, both IL-1α-KO lines may yield similar results due to the temporal dynamics of IL-1β production .
The specific role of IL-1α in regulating KC/CXCL1 expression provides a foundation for studying IL-1α-dependent neutrophil recruitment. Recommended protocols include:
In vitro approach:
In vivo approach:
This methodology allows researchers to specifically attribute neutrophil recruitment effects to IL-1α or IL-1β in various inflammatory contexts.
Proper experimental design with appropriate controls is essential when working with IL-1α knockout mice:
Genetic controls:
Wild-type littermates as primary controls
IL-1β knockout mice to distinguish IL-1α-specific effects
IL-1R knockout mice to confirm receptor dependency
Validation controls:
Experimental controls:
The distinction between acute and chronic inflammation is critical when interpreting results from IL-1α knockout models:
Acute inflammation:
Chronic inflammation:
This temporal dynamic explains why previous studies using IL-1α-KO line1 in chronic disease models were able to distinguish IL-1α-specific functions despite the model's limitations in acute inflammatory studies .
Thorough validation of IL-1α knockout models should include multiple complementary approaches:
Genomic verification:
Protein expression analysis:
Functional validation:
When faced with discrepant results between IL-1α and IL-1β knockout models, researchers should consider:
Temporal dynamics: IL-1α and IL-1β may have different kinetics of expression and action. The IL-1α-KO line1 showed reduction in IL-1β primarily at early timepoints .
Context-specific effects: The increased KC production observed in IL-1β knockout cells treated with LPS+ATP suggests competition between IL-1α and IL-1β for IL-1R binding, where increased availability of IL-1R for IL-1α binding may promote hyperexpression of select inflammatory factors in the absence of IL-1β .
Compensatory mechanisms: Long-term absence of one cytokine may lead to compensatory production of other inflammatory mediators.
Cell type-specific responses: Different cell types may have distinct dependencies on IL-1α versus IL-1β signaling.
When analyzing data from IL-1α knockout experiments, appropriate statistical approaches include:
For comparing cytokine levels between genotypes:
Two-way ANOVA with Tukey's post-hoc test for multiple comparisons across genotypes and treatments
Repeated measures analysis for time-course experiments
For neutrophil recruitment studies:
Non-parametric tests (Mann-Whitney) if data doesn't follow normal distribution
Consider power analysis to determine appropriate sample sizes based on expected effect size
For comprehensive evaluation:
Sample sizes should be determined based on anticipated biological variability, with a minimum of 3-5 biological replicates per condition for in vitro studies and 8-12 animals per group for in vivo experiments.
Researchers frequently encounter difficulties in detecting IL-1α protein expression:
Low basal expression: IL-1α is often expressed at low levels in resting cells and requires stimulation for robust detection. Use strong TLR stimuli like LPS (100 ng/ml) for at least 3-6 hours to induce detectable expression .
Detection methods: Western blotting requires optimization of lysis conditions as IL-1α can be cell-associated. Include positive controls (LPS-stimulated wild-type macrophages) and verify antibody specificity using IL-1α knockout cells .
Subcellular localization: IL-1α can be nuclear, cytoplasmic, or membrane-associated depending on cell type and activation state. Consider fractionation approaches when analyzing localization.
Processing variations: IL-1α can exist as both full-length and processed forms. Use antibodies that recognize both forms or specific domains depending on experimental questions .
Several strategies help minimize confounding factors in IL-1α knockout studies:
Genetic background standardization:
Microbiome considerations:
Co-house experimental groups or use littermates
Consider microbiome analysis in intestinal inflammation studies
Use germ-free facilities for highly sensitive phenotypes
Age and sex matching:
Use age-matched controls (particularly important in aging studies)
Include both sexes or justify single-sex usage
Analyze sex as a biological variable when appropriate
Experimental blinding:
Advanced techniques for studying IL-1α in complex models include:
Conditional knockout approaches:
Cell-type specific deletion using Cre-loxP systems
Inducible deletion using tamoxifen-responsive Cre
Tissue-specific promoters driving Cre expression
Reporter systems:
IL-1α-GFP fusion proteins to track expression and localization
IL-1α promoter-driven reporter genes to monitor transcriptional regulation
Dual reporters for simultaneous tracking of IL-1α and IL-1β
Single-cell analysis:
scRNA-seq to identify IL-1α-producing cell populations
CyTOF for high-dimensional protein profiling
Imaging mass cytometry for spatial context
In vivo imaging:
The recombinant mouse IL-1α protein is typically produced in Escherichia coli (E. coli) as a single, non-glycosylated polypeptide chain. This chain contains 179 amino acids and has a molecular mass of approximately 20.4 kDa . The protein is fused to a 23 amino acid His-tag at the N-terminus, which facilitates its purification through chromatographic techniques .
IL-1α exerts its effects by binding to specific cell surface receptors. It is known to stimulate thymocyte proliferation by inducing the release of IL-2, promote B-cell maturation and proliferation, and enhance fibroblast growth factor activity . Additionally, IL-1α is identified as an endogenous pyrogen, meaning it can induce fever by stimulating the release of prostaglandins .
For optimal stability, the IL-1α protein solution should be stored at 4°C if it will be used within 2-4 weeks. For longer storage periods, it is recommended to freeze the solution at -20°C and add a carrier protein such as 0.1% human serum albumin (HSA) or bovine serum albumin (BSA) to prevent degradation . It is important to avoid multiple freeze-thaw cycles to maintain the protein’s integrity.
IL-1α is intended for laboratory research use only and is not suitable for use as a drug, agricultural or pesticidal product, food additive, or household chemical . Researchers handling this protein should follow appropriate safety protocols to ensure safe and effective use.
In summary, recombinant mouse IL-1α with a His-tag is a valuable tool for studying the mechanisms of inflammation and immune responses. Its production in E. coli and subsequent purification allow for high-quality protein suitable for various research applications.